SAHA and hemangiosarcoma: another view.

L. A. Cohen, B. Powers, S. Amin, D. Desai, Treatment of canine haemangiosarcoma with suberoylanilide hydroxamic acid, a histone deacetylase inhibitor Veterinary and Comparative Oncology. ,vol. 2, pp. 243- 248 ,(2004) , 10.1111/J.1476-5810.2004.00057.X

Gregory K. Ogilvie, Barbara E. Powers, Craig H. Mallinckrodt, Stephen J. Withrow, Surgery and doxorubicin in dogs with hemangiosarcoma. Journal of Veterinary Internal Medicine. ,vol. 10, pp. 379- 384 ,(1996) , 10.1111/J.1939-1676.1996.TB02085.X

Michael Goldschmidt, Lili Duda, Karin Sorenmo, Amy Usborne, Frances Shofer, Lisa Barber, Kim Cronin, Carl Sammarco, Canine hemangiosarcoma treated with standard chemotherapy and minocycline. Journal of Veterinary Internal Medicine. ,vol. 14, pp. 395- 398 ,(2000) , 10.1892/0891-6640(2000)014<0395:CHTWSC>2.3.CO;2

William L. Spangler, Philip H. Kass, Pathologic factors affecting postsplenectomy survival in dogs. Journal of Veterinary Internal Medicine. ,vol. 11, pp. 166- 171 ,(1997) , 10.1111/J.1939-1676.1997.TB00085.X

Marissa Samluk, Beth Overley, Katherine A Skorupski, Craig A. Clifford, Jennifer L. Baez, Roxanne Bachman, Karin U. Sorenmo, Elizabeth Mauldin, Frances Shofer, Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma. Journal of Veterinary Internal Medicine. ,vol. 18, pp. 209- 213 ,(2004) , 10.1892/0891-6640(2004)18<209:EATOAD>2.0.CO;2

I D Kurzman, E G MacEwen, R R Dubielzig, S C Helfand, D M Vail, C O Rodriguez, B R Madewell, C A London, J E Obradovich, W C Kisseberth, Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clinical Cancer Research. ,vol. 1, pp. 1165- 1170 ,(1995)